Showing 1 posts of 1 posts found.
Findings presented at EULAR this week from the first real-world study in patients with rheumatic diseases supports switching from J&J’s …
NEC joins €6.5m European project using AI for pandemic vaccine design
The evidence bar impacting UK medical cannabis access
Survey highlights mental health burden among rare disease patients and families
Addressing the rheumatic disease diagnostic gap in primary care
How chronic disease creates opportunity on diagnostic and therapeutic pipelines